Aerovate Therapeutics Inc AVTE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
20.29UNCH (UNCH)
Volume
1,777
Close
20.29quote price arrow down-0.46 (-2.22%)
Volume
98,172
52 week range
9.41 - 32.42
Loading...
  • Open21.00
  • Day High22.34
  • Day Low19.99
  • Prev Close20.75
  • 52 Week High32.42
  • 52 Week High Date04/01/24
  • 52 Week Low9.41
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap583.081M
  • Shares Out28.74M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change-10.34

KEY STATS

  • Open21.00
  • Day High22.34
  • Day Low19.99
  • Prev Close20.75
  • 52 Week High32.42
  • 52 Week High Date04/01/24
  • 52 Week Low9.41
  • 52 Week Low Date10/30/23
  • Market Cap583.081M
  • Shares Out28.74M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change-10.34

RATIOS/PROFITABILITY

  • EPS (TTM)-2.87
  • P/E (TTM)-7.08
  • Fwd P/E (NTM)-6.71
  • EBITDA (TTM)-81.313M
  • ROE (TTM)-63.95%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aerovate Therapeutics Inc

 

Profile

MORE
Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension (PAH), a devastating disease impacting approximately 70,000 people in the United States and Europe. Oral imatinib also demonstrated...
Mark Iwicki
Independent Chairman of the Board
Timothy Noyes
Chief Executive Officer, Director
Benjamin Dake Ph.D.
President, Chief Operating Officer, Secretary
George Eldridge
Chief Financial Officer, Treasurer
Address
930 Winter Street, Suite M-500
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
HLVX
Hillevax Inc
13.61-0.41-2.92%
SVRA
Savara Inc
4.71+0.03+0.53%
PRME
Prime Medicine Inc
5.59-0.02-0.36%
PHAT
Phathom Pharmaceuticals Inc
10.04+0.28+2.87%
MLYS
Mineralys Therapeutics Inc
12.95-0.14-1.07%